Single Task Exercise Training for Parkinson's (NCT07641569)

Reduce walking problems when multitasking

Trial ID
NCT07641569
Official Title
Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease
Goal
Reduce walking problems when multitasking
Phase
NA
Status
RECRUITING
Sponsor
Saglik Bilimleri Universitesi
Study Type
INTERVENTIONAL
Enrollment
39 participants
Conditions
Parkinson's Disease (PD)
Interventions
Single Task Exercise Training, Motor-Motor Dual Task Exercise Training, Cognitive-Motor Dual Task Exercise Training

Summary For Families

The trial compares two kinds of "dual-task" exercise to see which better helps people with Parkinson's in movement, balance, walking, everyday activities, doing two things at once, thinking during movement, and confidence in balance. One program has people do two physical tasks at once, the other combines a thinking task with a movement task, and both are compared with regular single-task exercise; training is at the clinic twice a week for about 45 minutes each visit for six weeks, with assessments before and after. They are looking for adults age 40 and up who were diagnosed with Parkinson's by a neurologist and are in early to mid stages of the disease, roughly stages 1 to 3 on a common Parkinson's scale. People with other neurological diseases, significant memory or thinking problems (below 24 on the Standardized Mini Mental Test), prior deep brain stimulation surgery, major vision or hearing problems, or orthopedic issues that affect walking and balance are not eligible.

Locations

  • Gülhane Faculty of Physiotherapy and Rehabilitation, Ankara, Keçiören, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Single Task Exercise Training. The trial compares two kinds of "dual-task" exercise to see which better helps people with Parkinson's in movement, balance, walking, everyday activities, doing two things at once, thinking during movement, and confidence in balance. One program has people do two physical tasks at once, the other combines a thinking task with a movement task, and both are compared with regular single-task exercise; training is at the clinic twice a week for about 45 minutes each visit for six weeks, with assessments before and after. They are looking for adults age 40 and up who were diagnosed with Parkinson's by a neurologist and are in early to mid stages of the disease, roughly stages 1 to 3 on a common Parkinson's scale. People with other neurological diseases, significant memory or thinking problems (below 24 on the Standardized Mini Mental Test), prior deep brain stimulation surgery, major vision or hearing problems, or orthopedic issues that affect walking and balance are not eligible.
Who can participate?
Participants must be at least 40 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 3 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
How many visits does this trial involve?
You will come to the study clinic twice a week for approximately 45 minutes each session for 6 weeks, and you will have assessments at the clinic before and after the training.

Related Reading

View on ClinicalTrials.gov